Sinovac Biotech Ltd
NASDAQ:SVA

Watchlist Manager
Sinovac Biotech Ltd Logo
Sinovac Biotech Ltd
NASDAQ:SVA
Watchlist
Price: 6.47 USD Market Closed
Updated: May 17, 2024

Sinovac Biotech Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sinovac Biotech Ltd
Interest Income Expense Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Sinovac Biotech Ltd
NASDAQ:SVA
Interest Income Expense
$189.6m
CAGR 3-Years
426%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Interest Income Expense
-¥59.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Interest Income Expense
¥445.8m
CAGR 3-Years
N/A
CAGR 5-Years
84%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Interest Income Expense
¥217.7m
CAGR 3-Years
N/A
CAGR 5-Years
134%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Interest Income Expense
-¥33.6m
CAGR 3-Years
38%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Interest Income Expense
¥100.8m
CAGR 3-Years
126%
CAGR 5-Years
96%
CAGR 10-Years
N/A

See Also

What is Sinovac Biotech Ltd's Interest Income Expense?
Interest Income Expense
189.6m USD

Based on the financial report for Dec 31, 2022, Sinovac Biotech Ltd's Interest Income Expense amounts to 189.6m USD.

What is Sinovac Biotech Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
426%

Over the last year, the Interest Income Expense growth was 90%. The average annual Interest Income Expense growth rates for Sinovac Biotech Ltd have been 426% over the past three years .